IRIS UniCatt

Bianco, Assunta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 1.435
NA - Nord America 1.296
AS - Asia 556
SA - Sud America 131
AF - Africa 18
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.443
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.283
DE - Germania 531
SE - Svezia 289
CN - Cina 209
SG - Singapore 185
IT - Italia 152
BR - Brasile 118
FR - Francia 95
UA - Ucraina 83
GB - Regno Unito 70
IE - Irlanda 67
ID - Indonesia 47
IN - India 43
FI - Finlandia 40
RU - Federazione Russa 27
TR - Turchia 18
BE - Belgio 17
KR - Corea 14
CI - Costa d'Avorio 13
AT - Austria 11
PL - Polonia 11
CA - Canada 8
IR - Iran 8
VN - Vietnam 8
AR - Argentina 7
NL - Olanda 7
HK - Hong Kong 6
IL - Israele 4
JP - Giappone 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
AU - Australia 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
ES - Italia 3
HU - Ungheria 3
NO - Norvegia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CH - Svizzera 2
EE - Estonia 2
HR - Croazia 2
LV - Lettonia 2
MA - Marocco 2
MK - Macedonia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AO - Angola 1
BD - Bangladesh 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
IQ - Iraq 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
LT - Lituania 1
MD - Moldavia 1
MU - Mauritius 1
NP - Nepal 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
TH - Thailandia 1
VE - Venezuela 1
Totale 3.443
Salva come PNG Salva come JPEG
Città #
Chandler 328
Singapore 118
Ashburn 91
Ann Arbor 71
Dublin 67
San Mateo 59
Jacksonville 57
Nürnberg 51
New York 50
Jakarta 47
Milan 40
Boston 28
Nanjing 28
Wilmington 28
Princeton 25
Beijing 24
Woodbridge 24
Dearborn 22
Los Angeles 21
Hefei 20
Moscow 20
Helsinki 19
Bremen 18
Marseille 18
Brussels 17
Rome 17
Pune 15
Izmir 14
Munich 14
Nuremberg 14
Seoul 14
Abidjan 13
Houston 13
Chicago 11
Norwalk 11
Cattolica 10
Frankfurt am Main 10
Lawrence 10
São Paulo 10
Redwood City 9
Seattle 9
Düsseldorf 8
Leawood 8
North Bergen 8
Shanghai 8
Boardman 7
Kunming 7
Nanchang 7
Andover 6
Detroit 6
Falkenstein 6
Hong Kong 6
Portsmouth 6
Atlanta 5
Changsha 5
Mountain View 5
Rovato 5
Shenyang 5
Tianjin 5
University Park 5
Vienna 5
Warsaw 5
Edinburgh 4
Fairfield 4
Fremont 4
Guangzhou 4
Hanoi 4
Hebei 4
Jiaxing 4
Lauterbourg 4
Redmond 4
Turku 4
Ardabil 3
Augusta 3
Belo Horizonte 3
Brooklyn 3
Caxias do Sul 3
Fuzhou 3
Goiânia 3
Guayaquil 3
Hangzhou 3
Ho Chi Minh City 3
London 3
Newark 3
Nibionno 3
Ottawa 3
Rio de Janeiro 3
Septeme 3
Toronto 3
Washington 3
A Coruña 2
Amsterdam 2
Anápolis 2
Bratislava 2
Bucharest 2
Budapest 2
Buenos Aires 2
Catania 2
Changchun 2
Chengdu 2
Totale 1.727
Salva come PNG Salva come JPEG
Nome #
Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis 219
Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab 212
CD8(+) T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI 173
T-bet, pSTAT1 and pSTAT3 expression in peripheral blood mononuclear cells during pregnancy correlates with post-partum activation of multiple sclerosis. 171
The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. 147
Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. 138
Lambert-Eaton Myasthenic Syndrome associated with gastric schwannoma 131
Epstein-Barr virus antibodies in serum and cerebrospinal fluid from Multiple Sclerosis, Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Amyotrophic Lateral 126
Demyelinating Encephalomyeloradiculitis with Balò-like lesions 124
Increased CD4(+)CD25(+)Foxp3(+) T Cells in Peripheral Blood of Celiac Disease Patients: Correlation with Dietary Treatment. 107
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 98
Glioblastoma in multiple sclerosis: a case report 83
Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients 81
Dominus effect: challenging complications of alemtuzumab-related thyroid autoimmunity 80
Epidemiology of intensive care unit-acquired sepsis in Italy: Results of the SPIN-UTI network 79
Fingolimod vs dimethyl fumarate in multiple sclerosis 75
Defining the disease course of TNFα blockers-associated Multiple Sclerosis 72
Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients 71
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 66
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 65
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 63
Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients 63
New onset of Susac syndrome after mRNA COVID-19 vaccine: a case report 62
Severe dyspnoea with alteration of the diffusion capacity of the lung associated with fingolimod treatment 59
Acyclovir-related kidney injury during alemtuzumab infusion 58
The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review 58
The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre 58
The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray) 57
Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies 56
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients 54
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 54
Cyclophosphamide in highly aggressive Marburg-like multiple sclerosis 50
Is serological response to SARS-CoV-2 preserved in MS patients on ocrelizumab treatment? A case report 49
Moving to fingolimod from natalizumab in multiple sclerosis: the ENIGM is not solved 46
Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study 45
Liposome-based nanoparticles impact on regulatory and effector phenotypes of macrophages and T cells in multiple Sclerosis patients 44
Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach 44
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod 40
CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis 38
Correction to: Prevalence and predictors of bowel dysfunction in a large multiple sclerosis outpatient population: an Italian multicenter study (Journal of Neurology, (2022), 269, 3, (1610-1617), 10.1007/s00415-021-10737-w) 33
The predictive value of CSF multiple assay in multiple sclerosis: A single center experience 30
Multiple Sclerosis Onset before and after COVID-19 Vaccination: Can HLA Haplotype Be Determinant? 25
A true isolated cognitive relapse in multiple sclerosis 23
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY) 22
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 20
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome 19
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study 14
Totale 3.502
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.708
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202022 0 0 0 0 0 0 0 0 0 0 0 22
2020/2021207 11 19 4 15 18 8 23 10 18 20 56 5
2021/2022391 35 16 19 41 13 11 9 61 23 23 54 86
2022/2023878 91 110 61 139 65 116 43 84 100 10 43 16
2023/2024414 19 94 14 21 18 69 35 14 7 20 44 59
2024/2025690 14 25 63 53 45 33 17 26 140 73 188 13
Totale 3.502